TrueBinding

True Binding

Biotechnology, 300 Lincoln Centre Dr Ste 200, Foster City, California, 94404, United States, 51-200 Employees

truebinding.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

Who is TRUEBINDING

Founded in 2016, TrueBinding Inc. is a clinical-stage biotherapeutic company researching and developing first-in-class monoclonal antibody drugs to treat Dementia and Alzheimer's Disease ...

Read More

map
  • 300 Lincoln Centre Dr Ste 200, Foster City, California, 94404, United States Headquarters: 300 Lincoln Centre Dr Ste 200, Foster City, California, 94404, United States
  • 2016 Date Founded: 2016
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Dongxu Sun CEO:   Dongxu Sun

industries-icon Industry: Biotechnology

SIC SIC Code: 8742

checked-icon Does something look wrong? Fix it. | View contact records from TRUEBINDING

TrueBinding Org Chart and Mapping

Employees

Brittney Krall

Environmental Health & Safety Specialist

Fan Chen

Senior Vice President

Ian Alonso

Manufacturing Associate Scientist

Taufeeq Ahmed

Director Vivarium / in Vivo

Zin Win

Cell Line Development Sciencist II

Aaron Lee

Talent Acquisition Specialist / Human Resources

Daniel Thorp

Senior Maintenance Technician

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding TrueBinding

Answer: TrueBinding's headquarters are located at 300 Lincoln Centre Dr Ste 200, Foster City, California, 94404, United States

Answer: TrueBinding's official website is https://truebinding.com

Answer: TrueBinding's revenue is $1 Million to $5 Million

Answer: TrueBinding's SIC: 8742

Answer: TrueBinding has 51-200 employees

Answer: TrueBinding is in Biotechnology

Answer: TrueBinding contact info: Phone number: Website: https://truebinding.com

Answer: Founded in 2016, TrueBinding Inc. is a clinical-stage biotherapeutic company researching and developing first-in-class monoclonal antibody drugs to treat Dementia and Alzheimer's Disease (AD).

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access